drugset / Trial / NCT00618241
Pharmacokinetic Study on Raltegravir and Lamotrigine
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to determine whether interactions between raltegravir and lamotrigine take place and to study the safety of the combination raltegravir/lamotrigine before used in HIV patients.
Timeline
- Start
- 2008-02
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lamotrigine | Small molecule | 100 mg | Oral |
| Subject | Raltegravir | Other / unclassified | 400 mg | Oral |